EU agency ponders approval for Moderna’s COVID-19 vaccine

AMSTERDAM (AP) – The European Union’s (EU) medicines agency was meting yesterday to consider giving the green light to Moderna Inc’s COVID-19 vaccine, a decision that would give the 27-nation bloc a second vaccine to use in the desperate battle to tame the virus rampaging across the continent.

The meeting of the European Medicines Agency’s (EMA) human medicines committee (CHMP) comes amid high rates of infections in many EU countries and strong criticism of the slow pace of vaccinations across the region of some 450 million people.

More details on Thursday’s Borneo Bulletin